Optometrists in Mount Sterling, KY Accepting Medicare
9 Optometrists found. Showing 1 - 9
 Bluegrass Vision Group Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 25 Sterling Way, Suite C, Mount Sterling, KY 40353 Phone: 859-498-4800 Fax: 859-498-2021 |
 Dr. Rebecca Conrad, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Sterling Way Ste C, Mount Sterling, KY 40353 Phone: 859-498-4800 |
 Dr. Edward T Jacobs, OPTOMETRIST Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 N Maysville St, Mount Sterling, KY 40353 Phone: 859-498-6001 Fax: 859-497-0222 |
Helderman & Jacobs Vision Center, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1 N Maysville St, Mount Sterling, KY 40353 Phone: 859-498-6001 Fax: 859-497-0222 |
Dr. Wayne A Helderman, OPTOMETRIST Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 N Maysville St, Mount Sterling, KY 40353 Phone: 859-498-6001 Fax: 859-497-0222 |
Hannah Kissick, OD Optometrist Medicare: Medicare Enrolled Practice Location: 633 Maysville Rd, Mount Sterling, KY 40353 Phone: 859-404-7686 Fax: 859-498-8160 |
Dr. Wesley Simmons Optometrist Medicare: Medicare Enrolled Practice Location: 25 Sterling Way Ste C, Mount Sterling, KY 40353 Phone: 859-498-4800 |
Dr. Justin Eric Coleman, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 25 Sterling Way, Ste C, Mount Sterling, KY 40353 Phone: 859-498-4800 Fax: 859-498-2021 |
Guerrant Eye Clinic, Psc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 122 Stone Trace Drive, Suite A, Mount Sterling, KY 40353 Phone: 888-497-2117 Fax: 859-497-2542 |
News Archive
Aeras and Crucell commence Phase II study of TB vaccine candidate in infants
Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.
FDA acknowledges receipt of resubmission of Human Genome Sciences' raxibacumab BLA
Human Genome Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for raxibacumab, a treatment for inhalational anthrax, and has established December 15, 2012 as the Prescription Drug User Fee Act (PDUFA) action date.
New cardiac genetic testing guidelines for health care professionals
An international panel of experts from The Heart Rhythm Society and the European Heart Rhythm Association issued new guideline recommendations for all health care professionals about cardiovascular genetic testing at the Heart Rhythm Society's 32nd Annual Scientific Sessions.
Research may help cancer centers provide better radiation therapy
Using complex computational algorithms based on repeated sampling, a University of Arkansas graduate student helped spearhead a project to develop a computer simulator that provides customized electron beam tunings for radiation therapy.
› Verified 1 days ago
Optometrists
Occupational Therapists
Physical Therapists
Chiropractors
Speech-Language Pathologists